Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02132611 · ClinicalTrials.gov registry record · NA

Coronary Orbital Atherectomy System Study

A NA study of CAD, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
100
Enrollment target
17
Study locations

NCT02132611 is a NA study of CAD that has completed, run by Abbott Medical Devices. The registered enrollment target is 100 participants, below the 2,020-participant average among 4 other CAD trials with a reported enrollment target (95% lower). The trial reports 17 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02132611, a NA study of CAD, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
17
Study locations

Study Summary

The purpose of the COAST clinical study data will be to utilize and to gain approval for commercializing the Micro Crown as part of the Coronary Orbital Atherectomy System (OAS).

Conditions Studied

Interventions

  • DEVICE Diamondback 360® Coronary OAS Micro Crown

Study Locations (17)

Florida

  • North Florida Regional Medical Center - Gainesville
  • Palm Beach Gardens - Jupiter
  • Munroe Regional Health System, Inc. - Ocala
  • Florida Hospital - Orlando
  • Tallahassee Research Institute - Tallahassee

New York

  • Mount Sinai Hospital New York - New York
  • Columbia University Medical Center - New York
  • St. Francis Hospital - Roslyn

North Carolina

  • Duke University - Durham
  • NC Heart and Vascular Research - Raleigh

Kanagawa

  • Shonan Kamakura General Hospital - Kamakura
  • Saiseikai Yokohamashi Tobu Hospital - Yokohama

Arizona

  • Chandler Regional Medical Center and Mercy Gilbert Medical Center - Chandler

Mississippi

  • Baptist Memorial Hospital/Stern Cardiovascular Foundation, Inc. - Southaven

Hokkaido

  • Sapporo Higashi Tokushukai Hospital - Sapporo

Miyazaki

  • Miyazaki Medical Association Hospital - Miyazaki

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-06
Est. Completion 2017-06
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT02132611

The ClinicalTrials.gov registry entry for NCT02132611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,020-participant average among 4 other CAD trials with a reported enrollment target (95% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with CAD appearing as the primary indexed condition, and to 1 intervention - of which Diamondback 360® Coronary OAS Micro Crown is the first listed.

NCT02132611 reports 17 study locations spanning 9 distinct geographic areas - top geographies include Florida, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02132611 about?

NCT02132611 is a clinical study titled "Coronary Orbital Atherectomy System Study". The purpose of the COAST clinical study data will be to utilize and to gain approval for commercializing the Micro Crown as part of the Coronary Orbital Atherectomy System (OAS).

What is the current status of trial NCT02132611?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-06. Estimated completion is 2017-06.

What conditions does trial NCT02132611 study?

This clinical trial studies the following conditions: CAD.

What interventions are being tested in trial NCT02132611?

The interventions under investigation include: Diamondback 360® Coronary OAS Micro Crown (DEVICE).

Who is sponsoring clinical trial NCT02132611?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02132611 being conducted?

This trial has 17 study locations across Arizona, Florida, Mississippi, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for CAD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.